68727-745-01 |
68727-745 |
HUMAN PRESCRIPTION DRUG |
VYXEOS |
(daunorubicin and cytarabine) liposome |
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION |
INTRAVENOUS |
20170803 |
N/A |
NDA |
NDA209401 |
Jazz Pharmaceuticals, Inc. |
CYTARABINE; DAUNORUBICIN |
100 mg/20mL; 44 mg/20mL |
20 mL in 1 VIAL (68727-745-01) |
68727-745-02 |
68727-745 |
HUMAN PRESCRIPTION DRUG |
VYXEOS |
(daunorubicin and cytarabine) liposome |
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION |
INTRAVENOUS |
20170803 |
N/A |
NDA |
NDA209401 |
Jazz Pharmaceuticals, Inc. |
CYTARABINE; DAUNORUBICIN |
100 mg/20mL; 44 mg/20mL |
40 mL in 1 CARTON (68727-745-02) |
68727-745-05 |
68727-745 |
HUMAN PRESCRIPTION DRUG |
VYXEOS |
(daunorubicin and cytarabine) liposome |
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION |
INTRAVENOUS |
20170803 |
N/A |
NDA |
NDA209401 |
Jazz Pharmaceuticals, Inc. |
CYTARABINE; DAUNORUBICIN |
100 mg/20mL; 44 mg/20mL |
100 mL in 1 CARTON (68727-745-05) |